小儿恶性淋巴瘤临床特点(附104例报告)

本文对1966年6月～1986年6月经病理或细胞学确诊的104例小儿恶性淋巴瘤的临床特点进行分析。其中何杰金氏病(HD)33例,非何杰金氏淋巴瘤(NHL)71例。首发浅表淋巴结78例(75%),结外淋巴瘤26例(25%)。颈浅淋巴结为首发部位占76%(59/78)。上腔静脉综合征者10.6(11/104),合并白血病8.6%(9/104),白血病患者以纵隔为首发部位者占55%(6/9)。Ⅰ期9例,Ⅱ期29例,Ⅲ期37例,Ⅳ期29例。放疗组占15%(16例),化疗组占26%(27例),综合治疗组59%(61例)。近期疗效:CR(肿瘤完全消失)30%,PR(部分有效)58%,S(稳定)4%,PD(进展)8%。总有效率88%(91/104)。3年存活率26.3%(24/91),5年存活率18%(15/83),存活8年以上11例,10年以上6例,其中无瘤健在5例。

CLINICAL FEATURES OF CHILDREN WITH MALIGNANT LYMPHOMA A REPORT OF 104 CASES

104 cases of children with malignant lymphoma in our hospital from June 1966 to June 1986 are reported. 84 were males and 20 females. Their ages ranged 6 to 12. These patients were 33 HD, 71 NHL. 9 in stage Ⅰ, 29 in stage Ⅱ, 37 in stage Ⅲ and 29 in stage Ⅳ. In this series B group was 55% (57/104). The clinical primary site of intranodular was 75% (78/104) and extranodular 25%(26/104). The treatment methods include rrdiotherapy alone 16, chemotherapy alone 27 and combination 61. The complete remission (CR) was 30% (31/104), partial remission (PR) 58% (60/104). Total repose rate was 88%. The overall 3 and 5 year survival rates were 26.3%(24/91) and 18%(15/83). Survivals of 10 years were 6 cases (no evidence of disease). It is indicated that the primary sites, clinical stages, pathology types, treatment methods and complete remission are the prognostic factors in children with malignant lymphoma. Errly diagnosis, clinical stage and treatment have been discussed briefly. It is emphasized that after treatment, follow-up and maitaining chemotherapy may prolong the life of the patients.